Lockbit gang claims breach of Crinetics Pharmaceuticals
Learn More
Crinetics Pharmaceuticals, a U.S.-based company focusing on the development and commercialization of treatments for endocrine diseases, is investigating a cybersecurity incident following claims by the LockBit ransomware group that they had compromised the company's data.
The incident was detected after Crinetics noted unusual activity within an employee's account, which was promptly disabled. The company activated its cybersecurity incident response procedures, initiated an in-depth investigation, engaged external cybersecurity experts for assistance, and informed law enforcement agencies.
Crinetics claims that the cybersecurity incident has not impacted its research databases or its operational capabilities.
No details are disclosed about impacted systems or individuals, breached data set.
